Vanish Therapeutics is developing nerve stimulation technology for opioid-free pain relief. Its system pairs a bioresorbable stimulation wire with an external power source, aiming to deliver treatment without leaving a permanent implant behind. Designed for acute and chronic pain, the wire gradually dissolves after its therapeutic work is complete, avoiding a separate removal procedure. [1]
The company grew from University of Pittsburgh research and was co-founded by Kevin Woeppel, Trent Emerick and Xinyan Tracy Cui. Their combined expertise in bioengineering and pain medicine supports a platform designed to simplify temporary nerve stimulation and expand options for patients managing pain. [2]